Amlodipine Besylate Tablet
Description
ROOTOPINE-2.5
Amlodipine Besylate 2.5 mg Tablets
Division: DIABGLYM
Composition
Each tablet contains:
Amlodipine Besylate IP equivalent to Amlodipine — 2.5 mg
Excipients — q.s.
Colour: Approved colour used
Dosage form: Oral tablet
Product Description
ROOTOPINE-2.5 contains Amlodipine 2.5 mg, a long-acting dihydropyridine calcium channel blocker formulated for the effective management of hypertension, chronic stable angina, vasospastic angina, and long-term cardiovascular risk reduction. Amlodipine provides sustained blood pressure control by relaxing vascular smooth muscle, reducing peripheral vascular resistance, and improving coronary blood flow.
Amlodipine 2.5 mg is commonly prescribed as a low-dose antihypertensive therapy for patients requiring gradual blood pressure reduction, elderly patients, individuals sensitive to higher doses of calcium channel blockers, patients with mild hypertension, and those requiring individualized dose titration. It helps reduce systolic and diastolic blood pressure, decrease cardiac workload, improve myocardial oxygen supply, and lower the risk of cardiovascular complications.
ROOTOPINE-2.5 is particularly beneficial for initiating antihypertensive therapy and for long-term blood pressure management through convenient once-daily administration.
Technical Knowledge of Amlodipine
Amlodipine selectively inhibits L-type calcium channels in vascular smooth muscle and cardiac muscle. By reducing calcium influx into vascular smooth muscle cells, it produces peripheral arterial vasodilation, decreases systemic vascular resistance, lowers afterload, and improves coronary artery perfusion.
Amlodipine has a long elimination half-life of approximately 30 to 50 hours, allowing effective once-daily dosing with stable 24-hour blood pressure control. It has minimal negative effects on cardiac conduction and myocardial contractility, making it suitable for a broad range of hypertensive patients.
Mechanism of Action
Amlodipine relaxes vascular smooth muscle, reduces peripheral vascular resistance, lowers systemic blood pressure, decreases afterload, improves coronary blood flow, enhances myocardial oxygen supply, and provides sustained antihypertensive and anti-anginal effects.
Key Benefits
Gentle and effective blood pressure reduction
Provides sustained 24-hour blood pressure control
Improves coronary blood flow
Reduces peripheral vascular resistance
Suitable for elderly and dose-sensitive patients
Supports gradual dose titration
Reduces cardiovascular risk
Convenient once-daily dosing
Suitable for long-term hypertension management under medical supervision
Clinical Applications
ROOTOPINE-2.5 is commonly prescribed for mild hypertension, elderly hypertensive patients, initiation of antihypertensive therapy, chronic stable angina, vasospastic angina, hypertension requiring low-dose therapy, and long-term cardiovascular risk reduction.
Facts About Amlodipine
Amlodipine is one of the most extensively prescribed antihypertensive medications worldwide and is recommended as first-line therapy in many international hypertension guidelines. The 2.5 mg strength is particularly useful for elderly patients, patients with low body weight, individuals prone to hypotension, and those requiring gradual dose escalation while maintaining effective blood pressure control.
Key Facts
Long-acting calcium channel blocker
Amlodipine 2.5 mg for low-dose blood pressure control
Provides sustained 24-hour antihypertensive action
Suitable for elderly and dose-sensitive patients
Supports long-term cardiovascular protection
Evidence-based antihypertensive therapy
Quality-assured pharmaceutical formulation
PCD Pharma Franchise Opportunity
ROOTOPINE-2.5 is an excellent product for PCD Pharma Franchise, Cardiology Franchise, and Cardio-Diabetic Franchise across India. The increasing prevalence of hypertension, diabetes, obesity, chronic kidney disease, and cardiovascular disorders creates strong prescription demand and long-term market potential for this formulation.
Why Choose ROOTOPINE-2.5 for PCD Pharma Franchise?
High prescription potential
Strong physician and cardiologist acceptance
Attractive monopoly franchise opportunity
Competitive pricing
Promotional support available
Visual aids and marketing inputs
Consistent product quality
Excellent repeat business potential
Third Party Manufacturing
Chemsroot Pharmaceutical offers Third Party Manufacturing of Amlodipine Besylate 2.5 mg Tablets with complete manufacturing support for pharmaceutical companies, marketers, exporters, and franchise businesses.
Our Third Party Manufacturing Services Include
Private label manufacturing
Contract manufacturing
Custom brand manufacturing
Loan license manufacturing
DCGI-compliant production
GMP-certified manufacturing
Batch manufacturing documentation
Product registration support
Customized packaging and artwork
Monopoly franchise packaging
Bulk manufacturing capability
Manufacturing Features
Pharmaceutical-grade raw materials
IP/BP/USP quality standards
In-process quality control
Finished product testing
Stability-oriented formulation
Moisture-controlled tablet manufacturing
Blister and Alu-Alu packaging options
ROOTOPINE-2.5 from DIABGLYM combines gentle blood pressure control, sustained 24-hour antihypertensive action, comprehensive cardiovascular protection, and high-quality pharmaceutical manufacturing, making it an ideal product for physicians, cardiologists, diabetologists, PCD Pharma Franchise partners, and Third Party Manufacturing clients seeking a reliable and evidence-based low-dose Amlodipine formulation.
